Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Patient Enrollment

Recent news which mentions Patient Enrollment

Axsome Therapeutics Commences Late-Stage Migraine Study
Tickers AXSM
Tags Biotech Patient Enrollment General
From Benzinga
Stoke Therapeutics Commences Initial-Stage Optic Nerve Disorder Study
Tickers STOK
Tags Biotech Patient Enrollment General
From Benzinga
Annovis Shares Gain As Late-Stage Parkinson's Disease Study Takes-off
Tickers ANVS
Tags Movers & Shakers Biotech Patient Enrollment
From Benzinga
Cue Biopharma Shares Decline Following Initial-Stage Metastatic Cancer Study Kicks-off
Tickers CUE
Tags General Patient Enrollment Biotech
From Benzinga
BridgeBio Shares Fall As Initial-Stage Rare Metabolic Disorder Study Kicks-off
Tickers BBIO
Tags BBIO Small Cap Biotech
From Benzinga
Palisade Bio Shares Drop Following Commencement Of Late-Stage Return Of Bowel Study
Tickers PALI
Tags Markets Penny Stocks Movers & Shakers
From Benzinga
Anixa Initiates Patient Dosing in Initial-Stage Ovarian Cancer Study
Tickers ANIX
Tags Penny Stocks General Patient Enrollment
From Benzinga
Virios Therapeutics Commences Mid-Stage Long-COVID Study
Tickers VIRI
Tags Benzinga Market News Health Care
From Benzinga
Avalo Therapeutics' Shares Climb Following Patient Dosing in Immunodeficiency Disorder Study
Tickers AVTX
Tags AVTX General Patient Enrollment
From Benzinga
Kymera Therapeutics Commences Initial-Stage Oncology Trials
Tickers KYMR
Tags Benzinga Market News Health Care
From Benzinga
Apellis Begins Paitent Dosing In Late-Stage Study Of Rare Kidney Disease Candidate
Tickers APLS
Tags Health Care Market News Benzinga
From Benzinga
Moderna Commences Late-stage Study of Flu Vaccine Candidate
Tickers MRNA
Tags MRNA Biotech Patient Enrollment
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.